Forget CRISPR Therapeutics: This Gene‑Editing Player Already Boasts the Profits It Dreams Of

The company got into the game by partnering with smaller drugmakers in this field, most notably CRISPR Therapeutics. The two ...
Earth.com

Canadian man becomes first human cured with prime gene editing

A 19-year-old Canadian man becomes the first human cured through prime gene editing after doctors corrected a rare genetic ...
STAT

Prime Medicine to seek approval for gene-editing treatment after two-patient trial

Prime Medicine's application will test an FDA that has promised to speed new gene-editing treatments but has recently spurned ...
Fierce Biotech

FDA illuminates new approval pathway for bespoke gene editing therapies

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

Redefining What's Possible with Gene Editing and ASO Therapies

We are in the golden age of science and technology, advancements in gene editing and ASO therapies are allowing doctors to deliver targeted, and in some cases one-time, interventions for conditions ...

After a baby became the world's first CRISPR gene editing therapy patient, CHOP wants to expand treatment to others

One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand ...
European Medical Journal

Gene Therapy Breakthrough Restores Key Function in Cystic Fibrosis

UCLA researchers use lipid nanoparticles to insert full CFTR gene into airway cells, restoring function and opening new avenues for CF therapy.

Engineers sharpen gene-editing tools to target cystic fibrosis

Engineers at the University of Pennsylvania and Rice University have refined a technology for editing individual genetic ...

Gene editing takes centre stage in FDA’s new rare disease approval pathway

"Gene editing takes centre stage in FDA’s new rare disease approval pathway" was originally created and published by ...

CRISPR Therapeutics AG (CRSP) a Moderate Buy, Per Wall Street

CRISPR Therapeutics AG (NASDAQ:CRSP) is among the ARK Invest Stock Portfolio: Top 10 Stock Picks for 2026, with a stake value ...
Earth.com

Gene-edited fungus, eyed as a meat replacement, is revolutionizing the food industry

Chinese scientists create modified fungus that tastes like meat, produces protein quickly, and uses 70 percent less land.

Scientists create world’s first tomatoes that smell like ‘buttered popcorn’

Scientists generate world’s first ’extraordinary aromatic tomato plants’ by simultaneously altering two key genes ...